Similarly, Jiang et al. reported that SHP2 inhibitor restrained the expression of stem cell marker in KRAS mutant NSCLC, and the function of CSCs derived sphere was significantly inhibited [63]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.